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Increasing concern on chronic radiation injuries should be treated properly for life-saving improvement of wound management
andquality oflife. Recently, regenerative surgical modalities should be attempted with the use ofnoncultured autologous adipose-
derived stem cells (ADSCs) with temporal artiﬁcial dermis impregnated and sprayed with local angiogenic factor such as basic
ﬁbroblast growth factor, and secondary reconstruction can be a candidate for demarcation and saving the donor morbidity.
Autologous adipose-derived stem cells, together with angiogenic and mitogenic factor of basic ﬁbroblast growth factor and an
artiﬁcial dermis, were applied over the excised irradiated skin defect and tested for Patients who were uneventfully healed with
minimaldonor-site morbidity, which lasts more than 1.5 years.
1.Introduction
There is an increasing worry on radiation injuries probably
caused by nuclear power plant (NPP) reactor accidents,
therapeutic irradiation for malignancy, and interventional
radiology (IRV) of unexpectedly prolonged ﬂuoroscopic
procedures for cardiovascular diseases such as arrhythmia,
ischemic heart diseases, or nuclear medicine of overdose
intake of the radioactive for nuclear medicine of internal
radiation therapy. The problems are concerning chronic
radiation injury as well as how to heal such local and
systemic injures acutely. Local chronic radiation injury is
resistant to conventional therapeutic modalities such as ﬂap
coverage or skin grafting because the deteriorated margins
are sometimes indistinguishable from normal intact tissue,
and thus suﬃcient enough debridements are not obtained
with surgeons’ naked eyes.
These conditions should be treated properly for the sake
of life saving and improvement of local wound healing [1].
However, data of total evidence-based clinical analysis were
not established yet. Authors’institute, Nagasaki University,is
selected as a global strategic center for radiation health risk
control by the Japan’s Ministry of Education, Culture, Sports
and Technology from FY 2007 to 2011 and exploring to
establish such therapeutic regimens, to prevent the radiation
injuries, and possibly to regenerate medical and surgical
therapy for radiation injuries by using patients’ own adipose
tissue-derived stem cell therapy.
Often seen chronic radiation injuries are well handled
by suﬃcient enough blood supply to the radiated tissues,
especially in the cartilage, bare bone, and hardened scar
tissues. For this purpose, local, distant, and microsurgi-
cal vascularized ﬂaps are applied. Recent development of
microvasculature of the skin and soft tissues including
the connective tissues plays major roles in attributing to
accelerate local wound healing. Also, externally administered
angiogenic growth factor such as basic ﬁbroblast growth
factor (bFGF) together with temporal wound coverage of
artiﬁcial skin substitute is very eﬀective for those patients
with severe injuries, patients with comorbidities, who are2 Stem Cells International
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Figure 1: Strategy of emergency radiation injury. Collaborative work with highly established internationalcenters and organ is proposed.
intolerant to the extensive and long surgeries [2]. Here,
chronic radiation-injured wounds are tested with non-
cultured autologous adipose-derived stem cells and clinical
implications are discussed.
2.Materialsand Methods
2.1. Treatment of Chronic Local Radiation Injury with Con-
ventional Methods and Stem Cells. Often experienced in
radiation therapy for malignancy, cardiovascular modalities
should be categorized as diﬃcult wounding with poor
vasculature or less healing potentials.
From January 1990 to April 2007, 10 (8 females and 2
male) patients who demonstrated chronic radiation injuries
such as telangiectasia, xerosis, epidermal atrophy karatoses,
and ﬁbrosis as well as deep ulcers in the costal ribs and
sternum by adjuvant radiation therapy after mastectomy
and prolonged ﬂuoroscopic procedures for cardiovascular
diseases were surgically treated.
Other selective clinical cases used angiogenic growth
factor namely human recombinant basic ﬁbroblast growth
factor (rh-bFGF), which is clinically approved and widely
usedforclinicalwoundsinJapanwithskinsubstitutes,which
are also clinicallyavailablenotonly inJapan butalso in many
other nations including USA, the majority of EU nations,
and several Asian counties, and the eﬀectiveness of using the
artiﬁcial skin substitutes in the chronic radiation injuries is
temporal coverage and sustainability of both internal and
external cells and growthfactors. Therefore, combined use of
bFGF and artiﬁcial skin substitute leads to improved quality
of wounds (scar tissue) as well as facilitated wound healing
[3].
One case was treated with non-cultured autologous
adipose-derived stem cell (ADSC) for chronic sacro-coccyg-
ealradiationulcerin2008,which wascausedbyatherapeutic
radiation at fractionate 50Gy at 40 years previously.
2.2. Methods. This study was approved by the Ethics Com-
mittee of the Nagasaki University Hospital, and written
informed consent was obtained from all patients (approved
no. 08070296) and partly supported by the Global COE
(Center of Excellence) Program E08, Global Strategic Center
for Radiation Health Risk Control, and it was funded
by the Japan Society for the Promotion of Science. This
national research grant enables us to investigate 3 main
themes related to radiation health risk: (1) atomic-bomb
disease followup cohort research with over 60-year con-
tinuous research history, (2) radiation basic science, and
(3) international radiation health research. Especially, this
radiation regeneration research was involved in further
international collaboration framework under international
organizations such as WHO (World Health Organiza-
tion) and IAEA (International Atomic Energy Agency)
(Figure 1).Stem Cells International 3
Figure 2: The Adipose-derived stem cells are processed in a closed-
circuit machine within 1.5 hours.
2.3. Harvesting of Adipose Tissue by Liposuction and Isolation
of ADSCs. 3–5mm incisions, two incisions in the abdomen,
four incisions in the thigh, and two incisions in the gluteal
region, were made on the abdominal region, the thigh, and
the gluteal region. The subcutaneous layer was inﬁltrated
with a lactated Ringer’s solution with addition of 0.5mL of
epinephrine and 25mL of 1% lidocaine per 500mL. Adipose
tissue was suctioned using an 18-G Becker cannula with a
50mL syringe. Total 250gram-fat tissues, 120grams from
theabdominalregion,80gramsfrom theglutealregions, and
50grams from the thighs were harvested.
ADSCs were isolated from the suctioned adipose tissue
by using the Celution system. (Cytori Therapeutics, Inc.,
USA). Brieﬂy, the suctioned adipose tissue was introduced
into theCelutioncell-processing device,which automatically
and aseptically extracts and concentrates the mononuclear
fraction of adipose tissue and removes unwanted or delete-
rious cells, cell and matrix fragments such as lipids. By using
the Celution system, a 5mL solution is added to isolated
ADSCs in about one and a half hour (Figure 2). The whole
procedure is ina closed circuitand this reducesthe chance of
the contamination.
The small portion of processed ADSCs was used for
the ex vivo cell culture and conﬁrmed the proliferation
and diﬀerentiation potential. The ADSCs-rich fraction was
then plated onto collagen type-I-coated plastic culture ﬂasks
in a serum-free medium for primate embryonic stem cells
(Primate ES medium, RiproCELL, Tokyo), and the cells,
clonallyexpanded,were collectedandstoredin LiquidNitro-
gen as the primary ADSCs. ADSCs were subcultured when
they reached to 80% conﬂuence. Cells were treated with
trypsin/EDTA solution,neutralizedwith tripsin-neutralizing
solution, and collected by centrifugation for 5 minutes at
1,200rpm. The pellectswere resuspended inafresh medium;
thenumberofcellswascounted,and3 ×105 cellswereplated
into T25 ﬂasks (25cm2) for subculture while the rest of the
cells were stored in liquid nitrogen.
2.4. Adipose-Derived Stem Cell Grafting and Postoperative
Management. For the scaﬀold purpose, we used the artiﬁcial
dermis (Terudermis, Olympus-Terumo Biomaterials Co.,
Ltd., Japan) (Figure 3). The Terudermis is composed of two
layers: a lower layer of bovine atelocollagen and an upper
layer comprising a silicone sheet which protects against
infection and dryness from the outside. After minimum
debridement, the Terdermis was multilayered and stacked
over freshly debrided wounds. The silicone sheets were
removed except top Terudermis. The two-thirds of isolated
ADSCs alone were injected; around the debrided wounds,
at the base of the wounds, and into Terudermis. Another
one-third of ADSCs was mixed with the autologous adipose
which was rinsed with a lactated Ringer’s solution. In
the Celution system, after isolating ADSCs, the disposable
cell collection plastic case one was again used to mix the
suctioned fat, which is rinsed separately in the 50-cc syringe
and repeated until the oil droplets are removed. After being
mixed, it was injected into a zone of hard ﬁbrotic tissue
around the debrided wounds in 2-cm width in all directions.
2.5. Angiogenic Growth Factor and Basic Fibroblast Growth
Factor (bFGF). Genetically recombinant human bFGF
(Fiblast, Trafermin) was purchased from Kaken Pharma-
ceutical Co., Inc (Tokyo, Japan). The Freeze-dried bFGF
was dissolved in 5mL of benzalkonium chloride containing
solution right before the ﬁrst use and stored at 4◦Cf o r
one day, with 300µL sprayed over 30cm2 area from 5cm
distance, and 0.3mL per day of this solution was applied
over the wound. One week after removing the silicone layer,
human recombinant ﬁbroblast growth factor (bFGF: Fiblast,
Kaken Co., Ltd., Japan) (Figure 4)w a ss p r a y e d .T h ew o u n d
was covered with nonadherent occlusive foam dressing.
3.Results
3.1. Treatment of Chronic Local Radiation Injury with Con-
ventional Method. All wounds were healed after several
surgical modalities. None of the cases was healed with single
procedure (2 to 6 surgeries, mean 4.3).
Of our cases, one breast-cancer patient was treated
by a standardized Halsted method with major and minor
pectoralis muscle, radical neck, and axillary and internal
mammary lymph node dissections. This patient has under-
gone 50-Gy fractionate radiation therapy postoperatively.
Theradiatedareashowedchestﬁstuladeeptothepleurawith
surrounding unhealthy hardened scar tissue and chronic
inﬂammation.
The whole aﬀected area was sequentially excised in 3
reconstructivesurgeries,startingwithrectusabdominismus-
culocutaneous ﬂap, then latissimus dorsi musculocutanous
ﬂap, and ﬁnally with groin-free ﬂap. In the course after
each surgery, the margin of the ﬂap was partially dehiscent
and necrotized, which required further touchups? The total
number of the reconstructive surgery was 6 (Figure 5).
3.2. Treatment of Chronic Local Radiation Injury with
Adipose-Derived Stem Cells. Regeneration method with
patient’s own non-cultured ADSCs was planned for a patient
underwent 50-Gy fractionate radiation therapy for uterine
cancer 40 years ago. The pigmented sacrococcygeal region
appeared with central intractable wound. Necrotized bone
and fascia muscle along with malodour were observed.
The ADSCs-treated chronic radiation wounds underwent4 Stem Cells International
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Figure 3: Freeze-dried bilayer artiﬁcial dermis made of bovine dermis. The outer membrane of silicone layer is easily removed and easily
soaked with cell-containing solution.
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Figure 4: Commercially available growth factor and basic ﬁbroblast growth factor ( bFGF). Mode of action is explained and the mechanism
is proposed.
debridement to remove unhealthy superﬁcial necrotized
bone, fascia, periosteum, and muscle. 3.8 × 107 cells
in 5-mL of ﬁnal volume from 250mL of subcutaneous
aspirated fat obtained from nonradiated area were used.
Some ADSCs were directly injected in wound bed and
margins; others were soaked with the artiﬁcial dermis. In
a few days postoperatively, the silicone upper layer of the
artiﬁcial dermis (Terdermis) was removed, and bFGF was
sprayed over the regenerated wound for three weeks. There
was no signiﬁcant adverse eﬀect neither in donor site or
treated wound. The wound was healed uneventfully by day
82 and no sign of recurrence appeared, but the regenerated
tissue developed mature in 1.5 years (Figure 6).
4.Discussion
Local radiation injuries caused during medical therapy for
malignant tumors [4]a n dh e a r td i s e a s e[ 5] may be accom-
panied with systemic symptoms of hematologic, neurologic,
and gastrointestinal symptoms such as neutropenia, throm-
bopenia, fatigability, nausea, and diarrhea by contact to theStem Cells International 5
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Figure 5: 55-year-old woman underwent a left breast cancer surgery by a standardized Halsted methods, followed by 50-Gy fractionate
radiationtherapy 15 years previously. (a) The chest demonstrates ﬁstula to the costal rib and adjacent to the pleura as the arrow depicts, and
the surrounding tissues were ﬁrm and various-degree inﬂammation existed. (b) Sequential three major ﬂaps (rectus abdominis, latissimus
dorsi, and free groin ﬂap) are used for total coverage. (c) In 7 years postoperative view. There is irregularity of the scar margins.
scrap yard radioactive wastes without notice [6]o re x p o s u r e
to the radiation accidents [7] by touching gammagraphy
radioactive source by mistake [8]. Since locally radiated
tissues show decreased or insuﬃcient vascularity and tissue
damage, demonstrating erythema, teleangiectasia, pigmen-
tation, or dermal atrophy, once wound is developed, it is
often intractable and further leading to tissue necrosis, infec-
tion, and later ﬁbrosis in demonstrating chronic radiation
injury syndrome [9]. Therefore, radiation-injured wounds
tend to persist for a long time, show impaired healing, and
be prone to recurrence even by minor trauma. Radiated
wounds are treated by adequate debridement both in the
depth and in the width and covered with well-vascularized
tissues or by cultured bone-derived mesenchymal stem cells
[8]; however, the long-term outcome is not warranted, and
donor-site morbidity and the duration for treatment are
sometimes concerned, especially for the aged patients or
patients who somehow have problems in harvesting the
donors or being limited due to the coexisting diseases. As
seen in our reconstructive cases, the surgical modalities
constantly required multiple surgeries partly due to the
deﬁnitive damage-free margins of the aﬀected tissue.6 Stem Cells International
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Figure 6: 89-year-old woman underwent a uterine cancer surgery followed by 50-Gy fractionate radiation therapy 40 years previously. (a)
In 10 × 10cm area of radiation, 5 × 10cm area was exposed. Bone, fascia, and muscle as well as skin and fat were aﬀected. (b, c, d)
After careful debridement, 3.8 × 107 cells/5mL were applied over the wound bed and margins and soaked with artiﬁcial dermis. In a few
days postoperatively, bFGF was sprayed over the peeled-oﬀ inner regenerated tissue for 21 days. (e) In 1.5 years postoperative view. The
regenerated tissue remained durable, soft, and pliable.
Applicationof Stem cell therapies for repair and regener-
ation has recently been investigated at a clinical level in vari-
ouslydefectedorinjuredtissues, among which stemcellsand
adipose-derived stem cells (ADSCs) can be harvested with
a minimally invasive procedure by liposuction procedure
through a small incision. Similar to our method but in detail
very diﬀerent, Clinically puriﬁed autologous lipoaspirates
were used as treatment for radiotherapy tissue damage of
consecutive 20 patients. Indirectly, induced ADRCs have
potentialincelltherapyforradiationinjuryduetoincreasing
neovascularization and retention of the fat property [10].
This enables us to adopt this regeneration method for
patients with severe comorbidity such as elderly systemic
disease and physical wasting state (data not shown). TheStem Cells International 7
ADSCs contain several types of stem and regenerative cells,
including endothelial and smooth muscle cells and their
progenitors and preadipocytes [11] .T h eA D S C sh a v et h e
capacity to diﬀerentiate into multiple lineages and cell types
including mesodermal tissues such as fat, bone, cartilage,
endothelial cells of endodermal origin, and neurons and
epidermis of ectodermal origin as seen in the mesenchymal
stem cells [12].
Management of radiation injuries composes two major
parts. One is localized injuries and the other is of systemic
injuries. Among localized radiation injuries, chronic injuries
are more common in the medical ﬁeld after caner radiation
therapy. Usually management of these chronic wounds is
well handled by well-vascularized tissue transfers as various
plastic surgical procedures have proved. In consideration of
each patient general condition and preference, the choice of
therapeutic selections should be performed. On the other
hand, when the local radiation injuries are encountered
in an acute phase, there are high chances for innovative
procedures using autologous stem cells. The hMSCs are
resistant to radiation. We have previously demonstrated in
vitro cell proliferation curve and are also able to produce
protein avoiding cell apoptosis [13]. And the application of
cultured bone-derived mesenchymal stem cells successfully
healed severe local radiation wounds. However, the cultured
stemcelltherapytakeslongerperiodaslongas16daysbefore
cell therapy and required multiple (5 times) cell injections as
wellas 2skingrafting, 2ﬂaps, and1artiﬁcial dermiscoverage
[14]. Also, increasing evidences demonstrate that ADSCs
are similar to hMSCs in cell properties and characteristics
both in vitro and in vivo [11]. ADSCs are highly yielding
and less invasive for donor sites. The acute myocardial
infarction porcine models by improving left ventricular
function, perfusion, and remodeling [15]. When localized
radiation was distant enough from the donor sites adipose
tissues, immediate debridement and regeneration happens
using adipose-derived stem cells, which are available for
processing within 1.5 hours simultaneously in the same
operation theater without cell culture since adipose tissues
(fat tissues) are abundant in adult humans compared to
other stem cell sources. In the limited clinical circum-
stances of high-risk patients such as elderly and chronic
local infection, there is still opportunity of harvesting
and processing the patient’s own fat-derived stem cells
successfully as seen in our case. Practically for emergency
radiation injury cases, more abundant cell sources such
as fat are the primary candidate for this purpose. The
cell property and characterization of ADSCs are discussed
and discussed either fresh or cultured [16]. The results
from the clinical trial for acute myocardial infarction are
expected and may be applicable for acute radiation injury
treatment.
For treatment of systemic radiation injuries, stockpiled
stem cells should be globally available through medical
assistance network system under WHO-REMPAN, in which
Nagasaki University is highly involved in its activity, or
other international frameworks. Early resurfacing of the
damaged skin and subcutaneous tissues is as important as
hematological and intestinal system resuscitation [17].
Also, therapeutic guidelines for systemic radiation
injuries are anticipated from practical and regulatory view
points. Highlighting innovative technology and devices as
well as currently existing medicines and devices is expected
forthesakeofpreparingtotreat“systemic”radiationinjuries
most eﬀectively.
Therapeutic regimens of radiation injuries used to be
dependent on each subspecialty in the medical ﬁled such as
internal medicine, radiology, and surgery.
Recent establishment of wound care specialty was mostly
led by plastic surgeons, but other supporting specialists such
as nurses, dermatologists, and gastrointestinal physicians
and surgeons may be practically handling these rare but of
signiﬁcant impact “radiation injuries” as a interdisciplinary
approaches. Therefore, more specialization for “radiation
injuries” may be required.
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